InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
1
T+90 hit rate
100%
T+90 mean return
+17.2%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Squarer Ron, Director. Insider active across 2 companies, notably Travere Therapeutics, Inc.. Aggregated, 11 reports have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €19k. Activity tracked since 14 May 2021. The latest transaction was filed on 3 June 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Declarations11 total
45,000 shares0Common SharesSEC:0001628280-26-040492:0
15,196 shares@ US$3.0838.0% of flowCommon SharesSEC:0001628280-26-040492:1
15,184 shares@ US$3.5844.2% of flowCommon SharesSEC:0001628280-25-031895:0
40,000 shares0Common SharesSEC:0001628280-25-029724:0
6,500 shares0Common StockSEC:0001415889-25-013503:0
6,995 shares@ US$2.8917.8% of flowCommon SharesSEC:0001628280-24-028987:0
40,000 shares0Common SharesSEC:0001628280-24-028343:0
6,500 shares0Common StockSEC:0001415889-24-012851:0
4,500 shares0Common StockSEC:0001209191-23-030950:0
3,000 shares0Common StockSEC:0001209191-22-028703:0
3,000 shares0Common StockSEC:0001209191-21-033845:0
11 of 11 declarations
About Squarer Ron
Ron Squarer is a Board Member at Travere Therapeutics, Inc. He plays a key role in overseeing the company's activities and strategic decision-making. As a board member, Ron contributes to corporate governance and strategic direction, ensuring that Travere adheres to compliance and ethical standards. His experience in the biopharmaceutical industry enhances the company's ability to navigate a complex environment.
